Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$159.62
-4.6%
$174.59
$130.96
$182.89
$282.63B0.585.00 million shs10.72 million shs
Suncor Energy Inc. stock logo
SU
Suncor Energy
$39.41
-0.1%
$36.44
$27.59
$39.63
$50.73B1.133.99 million shs2.56 million shs
Visa Inc. stock logo
V
Visa
$274.52
-0.2%
$279.24
$216.14
$290.96
$504.16B0.966.53 million shs6.84 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-4.58%-4.09%-11.49%-2.91%-1.35%
Suncor Energy Inc. stock logo
SU
Suncor Energy
-0.03%+2.32%+8.12%+20.43%+34.67%
Visa Inc. stock logo
V
Visa
-0.21%+1.81%-1.59%+2.48%+20.35%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.9743 of 5 stars
3.43.04.23.93.72.52.5
Suncor Energy Inc. stock logo
SU
Suncor Energy
4.414 of 5 stars
3.35.03.30.02.41.71.3
Visa Inc. stock logo
V
Visa
4.8153 of 5 stars
3.42.03.33.23.72.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.77
Moderate Buy$177.4311.16% Upside
Suncor Energy Inc. stock logo
SU
Suncor Energy
2.63
Moderate Buy$52.0031.95% Upside
Visa Inc. stock logo
V
Visa
2.79
Moderate Buy$302.5810.22% Upside

Current Analyst Ratings

Latest V, SU, and ABBV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Visa Inc. stock logo
V
Visa
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$290.00 ➝ $300.00
4/24/2024
Visa Inc. stock logo
V
Visa
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$309.00 ➝ $315.00
4/24/2024
Visa Inc. stock logo
V
Visa
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$315.00 ➝ $325.00
4/24/2024
Visa Inc. stock logo
V
Visa
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/24/2024
Visa Inc. stock logo
V
Visa
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$314.00 ➝ $321.00
4/24/2024
Visa Inc. stock logo
V
Visa
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$280.00 ➝ $300.00
4/24/2024
Visa Inc. stock logo
V
Visa
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$297.00 ➝ $299.00
4/17/2024
Visa Inc. stock logo
V
Visa
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$314.00 ➝ $320.00
4/11/2024
Visa Inc. stock logo
V
Visa
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$320.00
3/28/2024
Suncor Energy Inc. stock logo
SU
Suncor Energy
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$50.00 ➝ $52.00
3/27/2024
AbbVie Inc. stock logo
ABBV
AbbVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $195.00
(Data available from 4/27/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$54.32B5.20$15.09 per share10.58$5.78 per share27.62
Suncor Energy Inc. stock logo
SU
Suncor Energy
$37.59B1.35$7.52 per share5.24$24.84 per share1.59
Visa Inc. stock logo
V
Visa
$32.65B15.44$10.37 per share26.47$21.17 per share12.97

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.86B$2.7358.4713.162.138.95%162.28%14.62%N/A
Suncor Energy Inc. stock logo
SU
Suncor Energy
$6.14B$4.708.3911.013.4816.33%16.08%7.76%5/13/2024 (Estimated)
Visa Inc. stock logo
V
Visa
$17.27B$8.9530.6725.051.8953.87%51.23%21.31%7/23/2024 (Estimated)

Latest V, SU, and ABBV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/26/2024Q1 24
AbbVie Inc. stock logo
ABBV
AbbVie
$2.26$2.31+$0.05$3.85$11.93 billion$12.31 billion    
4/23/2024Q2 2024
Visa Inc. stock logo
V
Visa
$2.43$2.51+$0.08$2.73$8.62 billion$8.78 billion    
2/21/202412/31/2023
Suncor Energy Inc. stock logo
SU
Suncor Energy
$0.80$0.93+$0.13$0.26$8.46 billion$10.39 billion    
2/2/202412/31/2023
AbbVie Inc. stock logo
ABBV
AbbVie
$2.76$2.79+$0.03$5.12$14.02 billion$14.30 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.203.88%+7.84%227.11%52 Years
Suncor Energy Inc. stock logo
SU
Suncor Energy
$1.614.09%+23.42%34.26%1 Years
Visa Inc. stock logo
V
Visa
$2.080.76%+15.30%23.24%16 Years

Latest V, SU, and ABBV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2024
Visa Inc. stock logo
V
Visa
quarterly$0.520.8%5/16/20245/17/20246/3/2024
2/15/2024
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.553.54%4/12/20244/15/20245/15/2024
2/21/2024
Suncor Energy Inc. stock logo
SU
Suncor Energy
Quarterly$0.40604.84%3/1/20243/4/20243/25/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
5.02
0.87
0.76
Suncor Energy Inc. stock logo
SU
Suncor Energy
0.26
1.44
0.88
Visa Inc. stock logo
V
Visa
0.53
1.40
1.45

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Suncor Energy Inc. stock logo
SU
Suncor Energy
67.37%
Visa Inc. stock logo
V
Visa
82.15%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
Suncor Energy Inc. stock logo
SU
Suncor Energy
1.00%
Visa Inc. stock logo
V
Visa
0.19%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.77 billionOptionable
Suncor Energy Inc. stock logo
SU
Suncor Energy
14,9061.29 billion1.27 billionOptionable
Visa Inc. stock logo
V
Visa
28,8001.84 billion1.83 billionOptionable

V, SU, and ABBV Headlines

SourceHeadline
Visa Inc. Expected to Post FY2024 Earnings of $9.92 Per Share (NYSE:V)Visa Inc. Expected to Post FY2024 Earnings of $9.92 Per Share (NYSE:V)
americanbankingnews.com - April 27 at 6:36 AM
Generational Wealth Builders: 3 Stocks to Own for Decades of GainsGenerational Wealth Builders: 3 Stocks to Own for Decades of Gains
investorplace.com - April 27 at 6:00 AM
3 No-Brainer Warren Buffett Stocks to Buy Right Now3 No-Brainer Warren Buffett Stocks to Buy Right Now
fool.com - April 27 at 6:00 AM
Seaport Res Ptn Brokers Lower Earnings Estimates for Visa Inc. (NYSE:V)Seaport Res Ptn Brokers Lower Earnings Estimates for Visa Inc. (NYSE:V)
americanbankingnews.com - April 27 at 5:54 AM
Is Visa the Best Dividend Stock for You?Is Visa the Best Dividend Stock for You?
fool.com - April 27 at 3:48 AM
Stanley Laman Group Ltd. Takes Position in Visa Inc. (NYSE:V)Stanley Laman Group Ltd. Takes Position in Visa Inc. (NYSE:V)
marketbeat.com - April 26 at 9:14 PM
Payments Giant Visa Rolls Out New Stablecoin Tool To Provide More Accurate Data on Transaction VolumesPayments Giant Visa Rolls Out New Stablecoin Tool To Provide More Accurate Data on Transaction Volumes
dailyhodl.com - April 26 at 3:16 PM
7 Must-Buy Stocks to Lock In a Luxurious Lifestyle7 Must-Buy Stocks to Lock In a Luxurious Lifestyle
investorplace.com - April 26 at 12:50 PM
Seaport Res Ptn Weighs in on Visa Inc.s FY2024 Earnings (NYSE:V)Seaport Res Ptn Weighs in on Visa Inc.'s FY2024 Earnings (NYSE:V)
marketbeat.com - April 26 at 9:28 AM
Cross River, Financially CLEAN and Visa Host Financial Literacy Event for NYC Students at the New York Stock ExchangeCross River, Financially CLEAN and Visa Host Financial Literacy Event for NYC Students at the New York Stock Exchange
businesswire.com - April 26 at 9:00 AM
Visa (NYSE:V) PT Raised to $299.00 at OppenheimerVisa (NYSE:V) PT Raised to $299.00 at Oppenheimer
americanbankingnews.com - April 26 at 8:38 AM
Visa (NYSE:V) PT Raised to $325.00Visa (NYSE:V) PT Raised to $325.00
americanbankingnews.com - April 26 at 8:38 AM
Visa (NYSE:V) Stock Rating Reaffirmed by William BlairVisa (NYSE:V) Stock Rating Reaffirmed by William Blair
americanbankingnews.com - April 26 at 8:06 AM
Wedbush Increases Visa (NYSE:V) Price Target to $300.00Wedbush Increases Visa (NYSE:V) Price Target to $300.00
americanbankingnews.com - April 26 at 8:06 AM
Visa (NYSE:V) PT Raised to $315.00Visa (NYSE:V) PT Raised to $315.00
americanbankingnews.com - April 26 at 7:06 AM
3 Recession-Proof Stocks to Add to Your Portfolio in 20243 Recession-Proof Stocks to Add to Your Portfolio in 2024
investorplace.com - April 26 at 6:30 AM
Visa (NYSE:V) PT Raised to $321.00Visa (NYSE:V) PT Raised to $321.00
americanbankingnews.com - April 26 at 5:40 AM
Visa Inc. Expected to Post Q3 2024 Earnings of $2.43 Per Share (NYSE:V)Visa Inc. Expected to Post Q3 2024 Earnings of $2.43 Per Share (NYSE:V)
americanbankingnews.com - April 26 at 2:40 AM
Visa Inc. Forecasted to Post Q3 2024 Earnings of $2.39 Per Share (NYSE:V)Visa Inc. Forecasted to Post Q3 2024 Earnings of $2.39 Per Share (NYSE:V)
americanbankingnews.com - April 26 at 2:40 AM
Visa appoints Sabbir Ahmed as country manager of Bangladesh, Nepal, BhutanVisa appoints Sabbir Ahmed as country manager of Bangladesh, Nepal, Bhutan
jagonews24.com - April 26 at 12:01 AM
Visa: One Of The Best Dividend Growers On The MarketVisa: One Of The Best Dividend Growers On The Market
seekingalpha.com - April 25 at 4:02 PM
Visa Joins the Amazon Partner Network As Fintechs Turn to the Cloud for Payments AcceptanceVisa Joins the Amazon Partner Network As Fintechs Turn to the Cloud for Payments Acceptance
digitaltransactions.net - April 25 at 1:59 PM
The Zacks Analyst Blog Highlights Visa, American Express and MastercardThe Zacks Analyst Blog Highlights Visa, American Express and Mastercard
finance.yahoo.com - April 25 at 1:59 PM
Bfsg LLC Purchases Shares of 3,528 Visa Inc. (NYSE:V)Bfsg LLC Purchases Shares of 3,528 Visa Inc. (NYSE:V)
marketbeat.com - April 25 at 11:37 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AbbVie logo

AbbVie

NYSE:ABBV
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Suncor Energy logo

Suncor Energy

NYSE:SU
Suncor Energy Inc. operates as an integrated energy company in Canada, the United States, and internationally. It operates through Oil Sands; Exploration and Production; and Refining and Marketing segments. The Oil Sands segment explores, develops, and produces bitumen, synthetic crude oil, and related products. This segment also engages in oil sands mining. The Exploration and Production segment is involved in offshore operations in the East Coast of Canada; and marketing and risk management of crude oil and natural gas. The Refining and Marketing segment engages in the refining of crude oil products; and distribution, marketing, transportation, and risk management of refined and petrochemical products, and other purchased products through the retail and wholesale networks. This segment is also involved in the trading of crude oil, refined products, natural gas, and power. The company was formerly known as Suncor Inc. and changed its name to Suncor Energy Inc. in April 1997. Suncor Energy Inc. was founded in 1917 and is headquartered in Calgary, Canada. Suncor Energy Inc.
Visa logo

Visa

NYSE:V
Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, deposit accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource that provides modular and value-added services for connecting merchants to payment processing; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Risk and Decision Manager, Visa Consumer Authentication Service, and payment-decisioning solutions for fraud prevention; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brand names. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California.